The Covid-19 vaccine made by Pfizer Inc and BioNTech SE was granted a full approval by US regulators, a move that is expected to help bolster the immunization drive amid a surge in infections caused by the delta variant.

The Food and Drug Administration said in a statement on Monday that it had cleared the vaccine for the prevention of Covid-19 in individuals 16 years of age and older. It will be marketed under the Comirnaty. 

The vaccine continues to be available to people age 12 to 15 under an emergency-use authorization, the agency said. 

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook